Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhabdomyosarcoma | 22 | 2023 | 358 | 2.490 |
Why?
|
Bone Neoplasms | 22 | 2023 | 2561 | 0.950 |
Why?
|
Osteosarcoma | 11 | 2022 | 908 | 0.830 |
Why?
|
Urogenital Neoplasms | 2 | 2018 | 130 | 0.640 |
Why?
|
Rhabdomyosarcoma, Alveolar | 7 | 2017 | 43 | 0.640 |
Why?
|
Muscle Neoplasms | 2 | 2015 | 130 | 0.550 |
Why?
|
Cytodiagnosis | 5 | 2019 | 450 | 0.520 |
Why?
|
Teratoma | 2 | 2023 | 405 | 0.510 |
Why?
|
ras Proteins | 2 | 2018 | 1055 | 0.460 |
Why?
|
Biopsy, Fine-Needle | 6 | 2014 | 1131 | 0.430 |
Why?
|
Head and Neck Neoplasms | 4 | 2018 | 2930 | 0.400 |
Why?
|
Soft Tissue Neoplasms | 11 | 2018 | 1163 | 0.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2023 | 11876 | 0.350 |
Why?
|
Rhabdomyosarcoma, Embryonal | 5 | 2022 | 99 | 0.340 |
Why?
|
Sarcoma | 7 | 2023 | 1802 | 0.330 |
Why?
|
Paired Box Transcription Factors | 5 | 2018 | 205 | 0.320 |
Why?
|
Child | 59 | 2023 | 80670 | 0.280 |
Why?
|
In Situ Hybridization, Fluorescence | 10 | 2021 | 2510 | 0.270 |
Why?
|
Anaplasia | 2 | 2020 | 16 | 0.270 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2021 | 1608 | 0.260 |
Why?
|
Surgical Flaps | 5 | 2008 | 1680 | 0.240 |
Why?
|
Child, Preschool | 41 | 2023 | 42577 | 0.240 |
Why?
|
Infant | 33 | 2023 | 36459 | 0.240 |
Why?
|
Scapula | 2 | 1999 | 175 | 0.240 |
Why?
|
Pathology | 1 | 2007 | 270 | 0.220 |
Why?
|
Gene Fusion | 3 | 2022 | 356 | 0.210 |
Why?
|
Carcinoma, Papillary | 3 | 2018 | 791 | 0.210 |
Why?
|
Lymphangioma | 1 | 2023 | 60 | 0.210 |
Why?
|
Immunohistochemistry | 12 | 2015 | 11062 | 0.200 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2021 | 43 | 0.190 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2815 | 0.190 |
Why?
|
Disease-Free Survival | 12 | 2023 | 6853 | 0.190 |
Why?
|
Hedgehog Proteins | 2 | 2018 | 771 | 0.180 |
Why?
|
Mitochondrial Diseases | 2 | 2015 | 344 | 0.180 |
Why?
|
Myogenin | 4 | 2014 | 54 | 0.170 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4968 | 0.170 |
Why?
|
Orbital Neoplasms | 2 | 2012 | 223 | 0.160 |
Why?
|
Lymphoma, T-Cell | 1 | 2002 | 308 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9407 | 0.160 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3530 | 0.160 |
Why?
|
Cartilage | 3 | 1999 | 811 | 0.150 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 571 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 497 | 0.150 |
Why?
|
Doxorubicin | 7 | 2023 | 2229 | 0.150 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2355 | 0.140 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.140 |
Why?
|
DNA Mutational Analysis | 5 | 2018 | 4114 | 0.140 |
Why?
|
Translocation, Genetic | 4 | 2021 | 1392 | 0.140 |
Why?
|
Adolescent | 34 | 2023 | 88902 | 0.140 |
Why?
|
Temporal Bone | 1 | 2002 | 683 | 0.140 |
Why?
|
Giant Cell Tumors | 2 | 1997 | 89 | 0.140 |
Why?
|
Spleen | 1 | 2023 | 2295 | 0.140 |
Why?
|
Muscle Cells | 1 | 2018 | 194 | 0.140 |
Why?
|
Neoplasms | 4 | 2019 | 22350 | 0.140 |
Why?
|
Humans | 102 | 2023 | 766812 | 0.140 |
Why?
|
Testicular Neoplasms | 1 | 2023 | 806 | 0.140 |
Why?
|
Meningitis, Aseptic | 1 | 1996 | 59 | 0.130 |
Why?
|
Chorioamnionitis | 2 | 1994 | 154 | 0.130 |
Why?
|
Gaucher Disease | 1 | 2017 | 110 | 0.130 |
Why?
|
Etoposide | 5 | 2023 | 638 | 0.130 |
Why?
|
Autopsy | 3 | 2014 | 1011 | 0.130 |
Why?
|
Vincristine | 6 | 2023 | 1040 | 0.130 |
Why?
|
Combined Modality Therapy | 10 | 2023 | 8540 | 0.130 |
Why?
|
Obstetric Labor, Premature | 2 | 1994 | 268 | 0.130 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 185 | 0.130 |
Why?
|
Cytochrome Reductases | 1 | 2015 | 9 | 0.130 |
Why?
|
Growth Plate | 2 | 1999 | 275 | 0.130 |
Why?
|
Amniotic Fluid | 2 | 1994 | 381 | 0.120 |
Why?
|
Cisplatin | 6 | 2019 | 1656 | 0.120 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2015 | 38 | 0.120 |
Why?
|
Microvilli | 1 | 2015 | 234 | 0.120 |
Why?
|
22q11 Deletion Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 811 | 0.120 |
Why?
|
Male | 60 | 2023 | 364154 | 0.120 |
Why?
|
Survival Rate | 7 | 2020 | 12826 | 0.120 |
Why?
|
Bone Transplantation | 1 | 1999 | 921 | 0.110 |
Why?
|
Mucolipidoses | 1 | 2015 | 82 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2018 | 374 | 0.110 |
Why?
|
Forensic Medicine | 1 | 2014 | 68 | 0.110 |
Why?
|
Malabsorption Syndromes | 1 | 2015 | 135 | 0.110 |
Why?
|
Female | 65 | 2023 | 396532 | 0.110 |
Why?
|
Skin Transplantation | 1 | 1999 | 1097 | 0.110 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 56 | 0.110 |
Why?
|
Acidosis, Lactic | 1 | 2015 | 144 | 0.110 |
Why?
|
Uterine Diseases | 1 | 1994 | 108 | 0.110 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 823 | 0.110 |
Why?
|
Optic Atrophy | 1 | 2014 | 79 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 56 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.110 |
Why?
|
Chondroma | 1 | 2013 | 53 | 0.110 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 12985 | 0.110 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 194 | 0.110 |
Why?
|
Muscles | 1 | 2018 | 1576 | 0.110 |
Why?
|
Sarcoma, Clear Cell | 1 | 2013 | 73 | 0.100 |
Why?
|
Leigh Disease | 1 | 2014 | 89 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2016 | 323 | 0.100 |
Why?
|
Contracture | 2 | 1994 | 236 | 0.100 |
Why?
|
Dactinomycin | 5 | 2018 | 304 | 0.100 |
Why?
|
Methotrexate | 5 | 2019 | 1719 | 0.100 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 541 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1540 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6514 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 291 | 0.100 |
Why?
|
Gene Amplification | 1 | 1996 | 1088 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2028 | 0.100 |
Why?
|
Heart Aneurysm | 1 | 2012 | 114 | 0.100 |
Why?
|
Limb Deformities, Congenital | 1 | 1992 | 136 | 0.090 |
Why?
|
Prognosis | 12 | 2020 | 29959 | 0.090 |
Why?
|
Frameshift Mutation | 1 | 2013 | 392 | 0.090 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4892 | 0.090 |
Why?
|
Genes, p53 | 1 | 2013 | 711 | 0.090 |
Why?
|
Thyroid Nodule | 2 | 2016 | 765 | 0.090 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 283 | 0.090 |
Why?
|
Drug Resistance, Multiple | 2 | 2007 | 256 | 0.090 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2234 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39312 | 0.090 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9244 | 0.090 |
Why?
|
Femur | 2 | 2013 | 1318 | 0.090 |
Why?
|
Hypercalcemia | 1 | 2013 | 425 | 0.090 |
Why?
|
Young Adult | 13 | 2023 | 59939 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
Osteotomy | 1 | 2015 | 837 | 0.080 |
Why?
|
Siblings | 1 | 2014 | 828 | 0.080 |
Why?
|
Thyroid Gland | 1 | 2016 | 1170 | 0.080 |
Why?
|
Adult | 32 | 2023 | 223305 | 0.080 |
Why?
|
Ornithine | 1 | 2009 | 79 | 0.080 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1130 | 0.080 |
Why?
|
Foot Ulcer | 1 | 2009 | 62 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 837 | 0.080 |
Why?
|
World Health Organization | 1 | 2015 | 1327 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2060 | 0.080 |
Why?
|
Topotecan | 3 | 2009 | 131 | 0.080 |
Why?
|
Infant, Newborn | 10 | 2023 | 26387 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 1996 | 1996 | 0.080 |
Why?
|
Heart Neoplasms | 1 | 2012 | 374 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2018 | 65286 | 0.070 |
Why?
|
Skin | 2 | 2009 | 4499 | 0.070 |
Why?
|
PAX7 Transcription Factor | 3 | 2014 | 55 | 0.070 |
Why?
|
RNA-Binding Protein EWS | 3 | 2021 | 211 | 0.070 |
Why?
|
Pressure Ulcer | 1 | 2009 | 158 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2014 | 4570 | 0.070 |
Why?
|
Abnormalities, Multiple | 2 | 2012 | 1424 | 0.070 |
Why?
|
Sarcoidosis | 1 | 2013 | 535 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2875 | 0.070 |
Why?
|
Mutation | 4 | 2018 | 30214 | 0.070 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2007 | 54 | 0.070 |
Why?
|
Sclerosis | 2 | 2005 | 211 | 0.070 |
Why?
|
Ear Neoplasms | 1 | 2008 | 118 | 0.070 |
Why?
|
Ear, External | 1 | 2008 | 165 | 0.070 |
Why?
|
Heel | 2 | 2009 | 38 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6066 | 0.070 |
Why?
|
Ifosfamide | 3 | 2015 | 233 | 0.070 |
Why?
|
Extremities | 1 | 1992 | 869 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1159 | 0.070 |
Why?
|
Neoadjuvant Therapy | 2 | 2015 | 2902 | 0.070 |
Why?
|
Ectromelia | 2 | 1999 | 28 | 0.070 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2007 | 238 | 0.070 |
Why?
|
Contrast Media | 2 | 2017 | 5329 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2306 | 0.070 |
Why?
|
Image Enhancement | 1 | 2017 | 2858 | 0.070 |
Why?
|
North America | 2 | 2023 | 1287 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 1089 | 0.060 |
Why?
|
Antigens, CD | 1 | 1996 | 4033 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 2 | 1994 | 2183 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6613 | 0.060 |
Why?
|
Hand Deformities, Congenital | 2 | 1999 | 175 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 1886 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 501 | 0.060 |
Why?
|
Hepatolenticular Degeneration | 1 | 2005 | 73 | 0.060 |
Why?
|
Kidney Diseases | 2 | 2014 | 2101 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1682 | 0.060 |
Why?
|
Survival Analysis | 7 | 2020 | 10101 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1263 | 0.060 |
Why?
|
Chondrosarcoma | 2 | 1997 | 305 | 0.050 |
Why?
|
Interleukin-1 | 2 | 1998 | 1251 | 0.050 |
Why?
|
Heart Arrest | 1 | 1993 | 1516 | 0.050 |
Why?
|
Mitral Valve | 1 | 2012 | 1473 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2252 | 0.050 |
Why?
|
Liver Failure, Acute | 1 | 2005 | 182 | 0.050 |
Why?
|
Sacrum | 1 | 2005 | 273 | 0.050 |
Why?
|
Lymphoma, B-Cell | 1 | 2009 | 945 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2131 | 0.050 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2002 | 36 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 18076 | 0.050 |
Why?
|
Liver | 2 | 2017 | 7571 | 0.050 |
Why?
|
In Situ Hybridization | 5 | 1998 | 1892 | 0.050 |
Why?
|
Hepatitis, Autoimmune | 1 | 2005 | 173 | 0.050 |
Why?
|
Glucose | 1 | 1994 | 4340 | 0.050 |
Why?
|
Retrospective Studies | 18 | 2023 | 81657 | 0.050 |
Why?
|
Burns | 1 | 1994 | 1902 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 7 | 2017 | 36570 | 0.050 |
Why?
|
Staining and Labeling | 4 | 2018 | 1075 | 0.050 |
Why?
|
Interleukin-6 | 3 | 1998 | 3226 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2013 | 3115 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4050 | 0.050 |
Why?
|
Paraffin Embedding | 3 | 2013 | 303 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2002 | 133 | 0.050 |
Why?
|
MyoD Protein | 3 | 2007 | 143 | 0.050 |
Why?
|
Barrett Esophagus | 2 | 1998 | 494 | 0.050 |
Why?
|
Bile Duct Neoplasms | 1 | 2007 | 614 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 1993 | 2058 | 0.050 |
Why?
|
Sensitivity and Specificity | 7 | 2014 | 14653 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2598 | 0.050 |
Why?
|
Interferon-alpha | 2 | 2015 | 910 | 0.040 |
Why?
|
Myocardium | 1 | 2013 | 4765 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2018 | 11657 | 0.040 |
Why?
|
DNA | 1 | 2014 | 7210 | 0.040 |
Why?
|
Risk Factors | 5 | 2022 | 74889 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4356 | 0.040 |
Why?
|
Aortic Valve Stenosis | 1 | 2012 | 2023 | 0.040 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1189 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8045 | 0.040 |
Why?
|
Schwann Cells | 1 | 2000 | 195 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2007 | 1885 | 0.040 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2000 | 131 | 0.040 |
Why?
|
Ankle | 1 | 1982 | 353 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 892 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2005 | 790 | 0.040 |
Why?
|
Femur Head Necrosis | 1 | 1999 | 133 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.040 |
Why?
|
Epiphyses | 1 | 1999 | 191 | 0.040 |
Why?
|
Trigeminal Nerve | 1 | 2000 | 248 | 0.040 |
Why?
|
Middle Aged | 19 | 2020 | 223267 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2800 | 0.040 |
Why?
|
Histological Techniques | 1 | 1998 | 193 | 0.040 |
Why?
|
Pain | 1 | 2013 | 5098 | 0.040 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1998 | 32 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4712 | 0.040 |
Why?
|
Osteoclasts | 2 | 2002 | 713 | 0.040 |
Why?
|
Genes, MDR | 1 | 1997 | 36 | 0.040 |
Why?
|
Gene Expression | 4 | 2013 | 7585 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2001 | 339 | 0.030 |
Why?
|
Osteochondroma | 1 | 1997 | 44 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4523 | 0.030 |
Why?
|
Meningitis, Viral | 1 | 1996 | 49 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4282 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2017 | 350 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7430 | 0.030 |
Why?
|
Cytogenetic Analysis | 2 | 2007 | 270 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2017 | 361 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1741 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1998 | 4349 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 386 | 0.030 |
Why?
|
Morocco | 1 | 2015 | 36 | 0.030 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2009 | 6359 | 0.030 |
Why?
|
Cartilage Diseases | 1 | 1997 | 160 | 0.030 |
Why?
|
DNA Probes | 1 | 1996 | 541 | 0.030 |
Why?
|
Metaplasia | 1 | 1996 | 326 | 0.030 |
Why?
|
Sarcoma, Synovial | 1 | 1996 | 157 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 281 | 0.030 |
Why?
|
Giant Cell Tumor of Bone | 1 | 1996 | 119 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2000 | 2551 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9515 | 0.030 |
Why?
|
Ventricular Dysfunction | 1 | 2015 | 143 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23618 | 0.030 |
Why?
|
Aged | 15 | 2016 | 171344 | 0.030 |
Why?
|
Radiotherapy | 2 | 2012 | 1497 | 0.030 |
Why?
|
Methylmalonyl-CoA Mutase | 1 | 2014 | 23 | 0.030 |
Why?
|
Ploidies | 1 | 1994 | 287 | 0.030 |
Why?
|
Iopamidol | 1 | 2014 | 188 | 0.030 |
Why?
|
Carcinoma, Small Cell | 1 | 1996 | 419 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2010 | 11218 | 0.030 |
Why?
|
Diet, Protein-Restricted | 1 | 2014 | 73 | 0.030 |
Why?
|
Aged, 80 and over | 8 | 2016 | 59548 | 0.030 |
Why?
|
Biopsy | 3 | 2002 | 6779 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2014 | 101 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 1996 | 403 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1996 | 314 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 175 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1996 | 240 | 0.030 |
Why?
|
Asia | 1 | 2015 | 629 | 0.030 |
Why?
|
Cohort Studies | 4 | 2019 | 41706 | 0.030 |
Why?
|
Nephritis | 1 | 2014 | 146 | 0.030 |
Why?
|
Nephrocalcinosis | 1 | 2013 | 51 | 0.030 |
Why?
|
Consanguinity | 1 | 2015 | 460 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1627 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2015 | 297 | 0.030 |
Why?
|
Bone Resorption | 1 | 1997 | 721 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2005 | 2186 | 0.030 |
Why?
|
Simplexvirus | 1 | 1996 | 805 | 0.030 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2012 | 30 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3796 | 0.030 |
Why?
|
Amniotic Band Syndrome | 1 | 1992 | 22 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2005 | 2416 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1996 | 680 | 0.030 |
Why?
|
Fatal Outcome | 2 | 1996 | 1838 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 320 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20710 | 0.030 |
Why?
|
Foot Deformities, Congenital | 1 | 1992 | 59 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 545 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2009 | 15425 | 0.030 |
Why?
|
Esophagus | 1 | 1998 | 1040 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2014 | 292 | 0.020 |
Why?
|
History, Ancient | 1 | 2012 | 213 | 0.020 |
Why?
|
Kidney Tubules, Proximal | 1 | 2014 | 386 | 0.020 |
Why?
|
Shoulder | 1 | 1994 | 300 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5330 | 0.020 |
Why?
|
Hydronephrosis | 1 | 2013 | 274 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1156 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 318 | 0.020 |
Why?
|
Axilla | 1 | 1994 | 622 | 0.020 |
Why?
|
Mitochondria | 2 | 2015 | 3678 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3552 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 2014 | 531 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12536 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2703 | 0.020 |
Why?
|
Developing Countries | 1 | 2023 | 2912 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2012 | 193 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 912 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3582 | 0.020 |
Why?
|
Fibula | 1 | 1992 | 270 | 0.020 |
Why?
|
Fetal Death | 1 | 2012 | 434 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5444 | 0.020 |
Why?
|
Histocytological Preparation Techniques | 1 | 2009 | 31 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13489 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1246 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2201 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2013 | 433 | 0.020 |
Why?
|
Radius | 1 | 1992 | 441 | 0.020 |
Why?
|
Mosaicism | 1 | 1993 | 480 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 367 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1276 | 0.020 |
Why?
|
Karyotyping | 2 | 2006 | 1176 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1631 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1992 | 992 | 0.020 |
Why?
|
Bone Remodeling | 1 | 1992 | 577 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2010 | 493 | 0.020 |
Why?
|
Ultrasonography | 2 | 2013 | 5990 | 0.020 |
Why?
|
Pediatrics | 1 | 2004 | 3614 | 0.020 |
Why?
|
Prospective Studies | 5 | 2016 | 54872 | 0.020 |
Why?
|
Incidental Findings | 1 | 2013 | 698 | 0.020 |
Why?
|
Kidney | 2 | 2014 | 7073 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3430 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 928 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3610 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2012 | 878 | 0.020 |
Why?
|
Base Sequence | 2 | 1996 | 12415 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 980 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6002 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10451 | 0.020 |
Why?
|
Brain | 1 | 2014 | 27158 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 1994 | 1597 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5922 | 0.020 |
Why?
|
Thyrotropin | 1 | 2010 | 834 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1320 | 0.020 |
Why?
|
Tibia | 1 | 1992 | 1071 | 0.020 |
Why?
|
Treatment Failure | 2 | 2004 | 2659 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17609 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16722 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2006 | 261 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1993 | 1776 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 1986 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 6968 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2669 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 192 | 0.020 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2006 | 104 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14073 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6507 | 0.020 |
Why?
|
Cystoscopy | 1 | 2005 | 128 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3667 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14473 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8728 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1992 | 980 | 0.010 |
Why?
|
Pregnancy | 4 | 2012 | 30236 | 0.010 |
Why?
|
Family | 1 | 2015 | 3209 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21162 | 0.010 |
Why?
|
Urine | 1 | 2005 | 363 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2013 | 2158 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2846 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9346 | 0.010 |
Why?
|
Bacteria | 1 | 1994 | 2212 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5985 | 0.010 |
Why?
|
Biological Assay | 1 | 2006 | 626 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18397 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2008 | 5890 | 0.010 |
Why?
|
Back | 1 | 1982 | 64 | 0.010 |
Why?
|
Mucins | 1 | 2005 | 569 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4914 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 1982 | 56 | 0.010 |
Why?
|
Macrophages | 1 | 1996 | 5784 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1762 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1992 | 1661 | 0.010 |
Why?
|
Biopsy, Needle | 2 | 1996 | 1615 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4047 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2002 | 327 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8928 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 20146 | 0.010 |
Why?
|
Life Tables | 1 | 2001 | 367 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9546 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81898 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24299 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5783 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168939 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40149 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2001 | 9101 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 325 | 0.010 |
Why?
|
Melphalan | 1 | 2001 | 425 | 0.010 |
Why?
|
Bronchiolitis Obliterans | 1 | 2001 | 221 | 0.010 |
Why?
|
S100 Proteins | 1 | 2000 | 215 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5038 | 0.010 |
Why?
|
Bone Marrow Diseases | 1 | 2001 | 234 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2916 | 0.010 |
Why?
|
Vimentin | 1 | 2000 | 257 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 6206 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1408 | 0.010 |
Why?
|
Neurofibromin 2 | 1 | 2000 | 269 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2629 | 0.010 |
Why?
|
United States | 3 | 2018 | 72945 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13642 | 0.010 |
Why?
|
Foot | 1 | 1982 | 576 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13644 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1794 | 0.010 |
Why?
|
Ankle Joint | 1 | 2001 | 452 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5306 | 0.010 |
Why?
|
Osteoblasts | 1 | 2002 | 1144 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1997 | 416 | 0.010 |
Why?
|
Cecal Neoplasms | 1 | 1996 | 27 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 1994 | 26309 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2002 | 1791 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2001 | 1788 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8623 | 0.010 |
Why?
|
Remission Induction | 1 | 2001 | 2413 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12430 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3600 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18329 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1697 | 0.010 |
Why?
|
Bone Diseases | 1 | 1997 | 412 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 1550 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13476 | 0.010 |
Why?
|
Anus Neoplasms | 1 | 1996 | 336 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 6214 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1995 | 462 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1993 | 412 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15835 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1993 | 432 | 0.010 |
Why?
|
Incidence | 2 | 2004 | 21527 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 8065 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1992 | 398 | 0.010 |
Why?
|
X Chromosome | 1 | 1993 | 819 | 0.010 |
Why?
|
Data Collection | 1 | 1998 | 3321 | 0.000 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3431 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1384 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12064 | 0.000 |
Why?
|
Population Surveillance | 1 | 1998 | 2594 | 0.000 |
Why?
|
Fetal Diseases | 1 | 1993 | 915 | 0.000 |
Why?
|
Sepsis | 1 | 2001 | 2604 | 0.000 |
Why?
|
Bone and Bones | 1 | 1997 | 2559 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3803 | 0.000 |
Why?
|
Health Care Costs | 1 | 1998 | 3240 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2002 | 15912 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1996 | 2535 | 0.000 |
Why?
|
Placenta | 1 | 1993 | 1726 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2000 | 7869 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 12795 | 0.000 |
Why?
|
Cell Line | 1 | 1993 | 15564 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1993 | 18986 | 0.000 |
Why?
|